A multicenter retrospective study examining the clinical characteristics of advanced non-small cell lung cancer patients with KRAS G12C mutation found an association between sotorasib toxicity and recent exposure to immune checkpoint inhibitors, which could also explain the occurrence of sotorasib-induced enteritis (Thummalapalli et al., 2023). Here, KRAS is linked to non-small cell lung carcinoma.